Arkolith/Insider Trading/THRX/Form 4

OrbiMed Capital GP VII LLC

Director, 10% OwnerTheseus Pharmaceuticals, Inc. (THRX) · full profile →Form 4 · filed Jan 21, 2022
Net Buying
Open-Market Buys
$1.6M
Open-Market Sells
$0
Net Open-Market Flow
$1.6M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2022Buy(P)112K$9.97$1.1M16.5M
Jan 20, 2022Buy(P)35K$9.95$348K16.4M
Jan 19, 2022Buy(P)12K$9.97$115K16.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-22-000087) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML